Pfizer drops after report on U.S. probe related to its COVID vaccine success

Exterior view of Pfizer Pharmaceutical company"s offices in Brussels, Belgium

Alexandros Michailidis/iStock Editorial via Getty Images

Pfizer (NYSE:PFE) shares fell on Wednesday after The Wall Street Journal reported that U.S. officials have started an investigation into whether the New York-based pharma giant deliberately delayed announcing the success of its Covid vaccine developed with BioNTech (NASDAQ:BNTX).

The

Leave a Reply

Your email address will not be published. Required fields are marked *